Frequency of Percutaneous Injuries Requiring Postexposure Prophylaxis for Occupational Exposure to Human Immunodeficiency Virus

Infection Control and Hospital Epidemiology

Volumn 19, Issue 7, 1998, Pages 504-506

  Sistrom, Maria Gilson ^a   Coyner, Betty Joe ^a   Gwaltney Jr , Jack M ^a   Farr, Barry M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROSS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEEDLESTICK INJURY; RISK FACTOR; UNITED STATES; UNIVERSITY HOSPITAL;

CROSS INFECTION; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; NEEDLESTICK INJURIES; RISK FACTORS; UNITED STATES; VIRGINIA;

EID: 0032113369     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141399     Document Type: Article

References (5)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1996;8(2):21.
2. Centers for Disease Control. Case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. MMWR 1995;44:929-933.
3. Centers for Disease Control and Prevention. Update: provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996;45:468-472.
4. Beekmann SE, Fahrner R, Gerberding JL, Koziol D, Henderson DK. Risk factors for HIV seroconversion in a prospective study of zidovudine (ZDV) post-exposure prophylaxis (PEP). In: Program and Abstracts of the Infectious Diseases Society of America 34th Annual Meeting; September 18-20, 1996; New Orleans, LA. Abstract 26.
5. Carpenter C, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1996. JAMA 1996;276:146-154.